'Promise Grants' Offer Individuals, Corporations Unique Opportunities to
Invest in Significant Collaborative Research Ventures
DALLAS, April 21 /PRNewswire/ -- Susan G. Komen for the Cure(R), the world's largest breast cancer organization, today announced the awarding of more than $100 million in research grants, representing the largest single-year investment in research in the organization's 26-year history and a 30 percent increase over last year's award total of $77 million. The 2008 grants slate moves Komen for the Cure closer to accomplishing its goal of investing another $2 billion in breast cancer research and community health programs by 2017.
With this year's slate of 143 grants, Komen for the Cure has fully activated new funding mechanisms designed to speed the discovery and delivery of the cures for breast cancer. The 2008 slate funds projects designed to promote breast cancer research collaboration and cost efficiencies, arrive at reliable and replicable research results more quickly, motivate bright young investigators to commit to breast cancer research careers and keep career researchers intensely focused on breast cancer.
"We've made it clear that our money will fund projects that focus on ways to significantly reduce breast cancer incidence and mortality within the next ten years," said Susan G. Komen for the Cure President and CEO Hala Moddelmog.
Specifically, Komen for the Cure is funding research initiatives
exploring key breast cancer issues, including genetic risks, risk
modulation, breast cancer stem cells, new targets for breast cancer
therapies, therapeutic vaccines, treatment resistance, the molecular basis
for chemotherapeutic response, strategies for the reduction of tumor
progression, the role of micro-environments, the role of specific pr
|SOURCE Susan G. Komen for the Cure|
Copyright©2008 PR Newswire.
All rights reserved